NxStage Medical (NxStage Medical) Price-to-Operating-Cash-Flow : 84.99 (As of Apr. 26, 2024)

View and export this data going back to 2005. Start your Free Trial

What is NxStage Medical Price-to-Operating-Cash-Flow?

As of today (2024-04-26), NxStage Medical's share price is $30.00. NxStage Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 was $0.35. Hence, NxStage Medical's Price-to-Operating-Cash-Flow Ratio for today is 84.99.

The historical rank and industry rank for NxStage Medical's Price-to-Operating-Cash-Flow or its related term are showing as below:

NXTM's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 21.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

NxStage Medical's Cash Flow from Operations per share for the three months ended in Sep. 2018 was $0.12. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 was $0.35.

NxStage Medical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NxStage Medical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NxStage Medical Price-to-Operating-Cash-Flow Chart

NxStage Medical Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

131.99

369.15

341.27

NxStage Medical Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															1,196.96	341.27	146.24	103.72	79.01

Competitive Comparison of NxStage Medical's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, NxStage Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NxStage Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NxStage Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NxStage Medical's Price-to-Operating-Cash-Flow falls into.

NxStage Medical Price-to-Operating-Cash-Flow Calculation

NxStage Medical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	30.00	/	0.353
	=	84.99

NxStage Medical's Share Price of today is $30.00.
NxStage Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.35.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

NxStage Medical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NxStage Medical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

NxStage Medical (NxStage Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NxStage Medical Inc (NAS:NXTM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nxstage.com

NxStage Medical develops and manufactures products and services for patients with chronic or acute kidney failure. The firm operates in three segments: System One, In-Center, and Services. The System One segment contributes the majority of revenue. It sells and rents the System One portable hemodialysis systems and related consumable products for home and critical care hemodialysis treatments. The In-Center segment sells blood tubing sets and needles for hemodialysis, primarily to dialysis clinics. This business has a high degree of customer concentration. The Services business provides dialysis to customers at NxStage Kidney Care dialysis centers. NxStage generates the majority of its revenue in the United States.

Executives

Earl R Lewis	director	C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
Craig W Moore	director	C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
Jeffrey H Burbank	director, officer: Chief Executive Officer	NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843
James J Peters	director	C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
Heyward R Donigan	director	452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jean K Mixer	director	C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
Kevin Hershberger	officer: Chief Accounting Officer	350 MERRIMACK STREET, LAWRENCE MA 01843
Philippe O. Chambon	director	C/O NEW LEAF VENTURE PARTNERS, 7 TIMES SQUARE, SUITE 3502, NEW YORK NY 10036
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Partners, L.p.	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield International Master Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017